deltatrials
Unknown PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT03271632

Multi-CAR T Cell Therapy in the Treatment of Multiple Myeloma

Multiple Antigen-specific CAR T Cells For the Treatment of Multiple Myeloma

Sponsor: Shenzhen Geno-Immune Medical Institute

Conditions Multiple Myeloma
Interventions CAR T cells
Updated 10 times since 2017 Last updated: Sep 18, 2019 Started: Jul 15, 2017 Primary completion: Dec 31, 2019 Completion: Dec 31, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Multiple Myeloma and is currently ongoing. Shenzhen Geno-Immune Medical Institute leads this study, which shows 10 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Oct 2017 – ~Nov 2017 · 31 days · monthly snapshotRecruiting~Nov 2017 – ~Feb 2018 · 3 months · monthly snapshotRecruiting~Feb 2018 – ~Mar 2018 · 28 days · monthly snapshotRecruiting~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotRecruiting~Jun 2018 – ~Oct 2019 · 16 months · monthly snapshotRecruiting~Oct 2019 – ~Jan 2021 · 15 months · monthly snapshotRecruiting~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotRecruiting~Oct 2021 – ~Jul 2024 · 33 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE1/PHASE2

    Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Oct 2021 — Jul 2024 [monthly]

    Unknown Status PHASE1_PHASE2

    Status: Recruiting → Unknown Status

  4. Jan 2021 — Oct 2021 [monthly]

    Recruiting PHASE1_PHASE2

  5. Oct 2019 — Jan 2021 [monthly]

    Recruiting PHASE1_PHASE2

▶ Show 5 earlier versions

  1. Jun 2018 — Oct 2019 [monthly]

    Recruiting PHASE1_PHASE2

  2. Mar 2018 — Jun 2018 [monthly]

    Recruiting PHASE1_PHASE2

  3. Feb 2018 — Mar 2018 [monthly]

    Recruiting PHASE1_PHASE2

  4. Nov 2017 — Feb 2018 [monthly]

    Recruiting PHASE1_PHASE2

  5. Oct 2017 — Nov 2017 [monthly]

    Recruiting PHASE1_PHASE2

    First recorded

Jul 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Shenzhen Geno-Immune Medical Institute
Data source: Shenzhen Geno-Immune Medical Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations